Showing results (1-10 of 30) with videos related to
Sort By:
Pageof 3
Therapeutic Advances in Gastroenterology|July 3, 2015
Docetaxel and its potential in the treatment of refractory esophagogastric adenocarcinomaHugo Ford, Ioannis GounarisJournal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|October 17, 2009
Capecitabine-induced cerebellar toxicity in a patient with metastatic colorectal cancerIoannis Gounaris, Athar AhmadFuture Oncology (London, England)|May 9, 2015
Molecular pathogenesis of ovarian clear cell carcinomaIoannis Gounaris, James D BrentonJOP : Journal of the Pancreas|March 9, 2010
Options for the treatment of gemcitabine-resistant advanced pancreatic cancerIoannis Gounaris, Kamarul Zaki, Pippa CorrieF1000Research|February 10, 2015
Application of ARID1A to murine formalin-fixed paraffin embedded tissue using immunohistochemistryWill Howat, Jodi Miller, Ioannis GounarisClinical Medicine (London, England)|February 3, 2016
Lesson of the month 2: Cauda equina in Cushing's syndromeDouglas Maslin, Ioannis Gounaris, Kenrick Ng, et al.The Journal of Pathology|September 8, 2011
Ovarian clear cell carcinoma--bad endometriosis or bad endometrium?Ioannis Gounaris, D Stephen Charnock-Jones, James D BrentonStatistics in Medicine|November 25, 2022
Practical implementation of the partial ordering continual reassessment method in a Phase I combination-schedule dose-finding trialPavel Mozgunov, Thomas Jaki, Ioannis Gounaris, et al.Anti-Cancer Drugs|September 26, 2007
Marked response to a cisplatin/docetaxel/temozolomide combination in a heavily pretreated patient with metastatic large cell neuroendocrine lung carcinomaIoannis Gounaris, Joe Rahamim, Siva Shivasankar, et al.BMC Medicine|September 23, 2015
Neoadjuvant trials in early breast cancer: pathological response at surgery and correlation to longer term outcomes - what does it all mean?Helena Earl, Elena Provenzano, Jean Abraham, et al.Pageof 3